Generalist and Subspecialist Physicians' Knowledge, Attitudes, and Practices Regarding Influenza and Pneumococcal Vaccinations for Elderly and Other High-Risk Patients
Open Access
- 10 December 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (22) , 2702-2708
- https://doi.org/10.1001/archinte.161.22.2702
Abstract
INFLUENZA AND pneumococcal diseases cause hundreds of thousands of hospitalizations and tens of thousands of deaths each year.1,2 In fact, these 2 vaccine-preventable diseases are responsible for more deaths than all other vaccine-preventable diseases combined, with more than 90% of these deaths occurring among the elderly and others with high-risk medical conditions.3This publication has 12 references indexed in Scilit:
- Published by American Medical Association (AMA) ,1999
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of internal medicine (1960), 1998
- Side effects associated with pneumococcal vaccinationAmerican Journal of Infection Control, 1997
- Factors associated with influenza and pneumococcal vaccination behavior among high-risk adultsJournal of General Internal Medicine, 1996
- Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trialArchives of internal medicine (1960), 1996
- Differences in Generalists' and Cardiologists' Perceptions of Cardiovascular Risk and the Outcomes of Preventive Therapy in Cardiovascular DiseaseAnnals of Internal Medicine, 1996
- Adult immunization. Summary of the National Vaccine Advisory Committee ReportPublished by American Medical Association (AMA) ,1994
- Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.BMJ, 1993
- Preventive Care for Women -- Does the Sex of the Physician Matter?New England Journal of Medicine, 1993
- Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trialJAMA, 1990